[XENE] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 23.06%
YoY- -24.78%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 9 132 536 8,766 3,737 8,124 2,218 -97.43%
PBT -36,256 -37,737 -31,198 -20,064 -25,080 -15,650 -22,326 38.03%
Tax 1,139 -587 -40 -394 484 -205 -217 -
NP -37,395 -37,150 -31,158 -19,670 -25,564 -15,445 -22,109 41.82%
Tax Rate - - - - - - - -
Total Cost 37,404 37,282 31,694 28,436 29,301 23,569 24,327 33.11%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -426,591.38 -28,143.94 -5,813.06 -224.39 -684.08 -190.12 -996.80 5516.63%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.57 -0.59 -0.55 -0.37 -0.62 -0.37 -0.53 4.95%
EPS Diluted -0.57 -0.57 -0.55 -0.36 -0.62 -0.37 -0.53 4.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.